动脉瘤性蛛网膜下腔出血潜在生物标记物的研究进展  

Research Progress on Potential Biomarkers of Aneurysmal Subarachnoid Hemorrhage

作　　者：张彦兵 吴红星[2] 

机构地区：[1]新疆医科大学研究生院,新疆 乌鲁木齐 [2]新疆维吾尔自治区人民医院神经外科,新疆 乌鲁木齐

出　　处：《临床医学进展》2024年第2期3604-3610,共7页Advances in Clinical Medicine

摘　　要：动脉瘤性蛛网膜下腔出血是一种常见的神经系统急症,有着极高的致死率和致残率,目前对于动脉瘤性蛛网膜下腔出血的检查及预后评估主要通过影像手段如CT、CTA、MRA、DSA来实现,但是这些检查手段有着严格的适应症、禁忌症、潜在造影剂和辐射威胁,此外术后患者需进行长期随访,观察脑动脉瘤的生长及预后情况,部分患者受到医疗、经济等条件限制。因此,寻找快捷、实用、有效和经济的评估方法来检测动脉瘤性蛛网膜下腔出血的治疗效果和预后是非常有必要的。Aneurysmal subarachnoid hemorrhage is a common neurological emergency with extremely high mortality and disability rates. Currently, the examination and prognosis evaluation of aneurysmal subarachnoid hemorrhage are mainly achieved through imaging methods such as CT, CTA, MRA, and DSA. However, these examination methods have strict indications, contraindications, potential contrast agents, and radiation threats. In addition, postoperative patients need to undergo long-term follow-up, observing the growth and prognosis of cerebral aneurysms, some patients are limited by medical and economic conditions. Therefore, it is necessary to find a fast, practical, effective, and economical evaluation method to detect the treatment effect and prognosis of aneu-rysmal subarachnoid hemorrhage.

关 键 词：动脉瘤性蛛网膜下腔出血 生物标记物 炎症反应 

分 类 号：R74[医药卫生—神经病学与精神病学]